Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025
CINCINNATI, July 29, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based...
Staff
uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress
~ Achieved alignment with the FDA on the AMT-130 statistical analysis plan and CMC requirements to support a planned BLA...
Novo Nordisk lowers sales and operating profit outlook for 2025
Bagsværd, Denmark, 29 July 2025 – Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for...
EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration
– LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong enthusiasm for the...
Microbix Launches QUANTDx™ Characterized Reference Materials
New Product Line Supporting Diagnostic Assay ManufacturersMISSISSAUGA, Ontario, July 29, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference
FRIENDSWOOD, Texas, July 29, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that...
Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease
Mean signs and symptoms for participants in Stage 3 of the SAHARA trial remained statistically significantly better than study baseline...
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference
Boca Raton, July 29, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) announced today that a video detailing the...
Pharmazz Inc. Announces Enrollment of First Patient in Phase 3 Clinical Trial of Sovateltide for Treating Patients with Cerebral Ischemic Stroke
The Phase 3 clinical trial of sovateltide, RESPECT-ETB, is expected to enroll over 500 patients with a primary endpoint of...
Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on August 12, 2025NASHVILLE, Tenn., July 29,...
Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025
PITTSBURGH, July 29, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced...
Ocular Therapeutix™ to Report Second Quarter 2025 Financial Results on August 5, 2025
BEDFORD, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining...
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025
― Announced results from the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of pociredir in sickle...
Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
― Robust and clinically meaningful absolute mean fetal hemoglobin (HbF) induction of 8.6% from baseline at 12 weeks of treatment;...
Glucose Health, Inc. (OTC: GLUC) Highlights U.S. Department of Health and Human Services Designation of Key Nutrient Validating Company’s Patent-Pending Nutrition Formulation via CNBC, Fox Business and Bloomberg Television Media Blitz
BENTONVILLE, Ark., July 29, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a publicly traded consumer healthcare company focused...
Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)
- Novel once-weekly injectable VMAT2 inhibitor targets underserved patients with serious adherence and access challenges – - Potential expansion into...
Republic Technologies Leverages Kraken to Advance Ethereum Infrastructure
Vancouver, British Columbia--(Newsfile Corp. - July 29, 2025) - Republic Technologies Inc. (CSE: DOCT) (FSE: 7FM) ("Republic" or the "Company")...
Red Light Holland Reports 2025 Audited Year-End Results – Demonstrates Continued Fiscal Discipline, Strategic Growth, and Psilocybin R&D Expansion
Toronto, Ontario--(Newsfile Corp. - July 29, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip(TM) to Combat Opiate Addiction Crisis
Burlington, Ontario--(Newsfile Corp. - July 29, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company,...
Tigermed Completes Acquisition of Japanese CRO Micron
HANGZHOU, China and TOKYO, July 29, 2025 /PRNewswire/ -- Tigermed (300347.SZ / 3347.HK), a leading global provider of clinical research...